Evidence
Geroscience. 2024 Feb 23. doi: 10.1007/s11357-024-01096-1. Online ahead of print.
ABSTRACT
The long COVID (coronavirus disease), a multisystemic condition following severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, is one of the widespread problems. Some of its symptoms affect the nervous system and resemble symptoms of Alzheimer’s disease (AD)-a neurodegenerative condition caused by the accumulation of amyloid beta and hyperphosphorylation of tau proteins. Multiple studies have found dependence between these two conditions. Patients with Alzheimer’s disease have a greater risk of SARS-CoV-2 infection due to increased levels of angiotensin-converting enzyme 2 (ACE2), and the infection itself promotes amyloid beta generation which enhances the risk of AD. Also, the molecular pathways are alike-misregulations in folate-mediated one-carbon metabolism, a deficit of Cq10, and disease-associated microglia. Medical imaging in both of these diseases shows a decrease in the volume of gray matter, global brain size reduction, and hypometabolism in the parahippocampal gyrus, thalamus, and cingulate cortex. In some studies, a similar approach to applied medication can be seen, including the use of amino adamantanes and phenolic compounds of rosemary. The significance of these connections and their possible application in medical practice still needs further study but there is a possibility that they will help to better understand long COVID.
PMID:38393535 | DOI:10.1007/s11357-024-01096-1
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Molecular cross-talk between long COVID-19 and Alzheimer’s disease
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Liver as a new target organ in Alzheimer's disease: insight from cholesterol metabolism and its role in amyloid-beta clearance
- Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer's Disease
- Alzheimer-Type Cerebral Amyloidosis in the Context of HIV Infection: Implications for a Proposed New Treatment Approach
- P2Y1 receptor in Alzheimer's disease
- Neuropsychiatric symptoms associated with the COVID-19 and its potential nervous system infection mechanism: the role of imaging in the study
- Hypoglycemia and Alzheimer Disease Risk: The Possible Role of Dasiglucagon
- Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer's disease
- Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study
- VEEV TC-83 Triggers Dysregulation of the Tryptophan-Kynurenine Pathway in the Central Nervous System That Correlates with Cognitive Impairment in Tg2576 Mice
- Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease
- Multiple system atrophy with amyloid-b-predominant Alzheimer's disease neuropathologic change
- Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis Patients
- Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer's disease
- Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer's disease
- Towards cascading genetic risk in Alzheimer's disease
- Phytoactive drugs used in the treatment of Alzheimer's disease and dementia
- The Gut Microbiota-Brain Axis: A New Frontier in Alzheimer's Disease Pathology
- Co-registration of MALDI-MSI and histology demonstrates gangliosides co-localize with amyloid beta plaques in Alzheimer's disease
- Co-registration of MALDI-MSI and histology demonstrates gangliosides co-localize with amyloid beta plaques in Alzheimer's disease
- Amyloid, Crohn's disease, and Alzheimer's disease - are they linked?
- Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer's disease
- Connecting the Dots: Gender, Sexuality, and Societal Influences on Cognitive Aging and Alzheimer's Disease
- Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease
- Post-GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3
- Genomic stress and impaired DNA repair in Alzheimer disease
- Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
- Neuroimmune Dysfunction in Alzheimer's Disease and Other Forms of Dementia
- Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold
- PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease
- Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics
- Biomarkers of Neurodegeneration and Alzheimer's Disease Neuropathology in Adolescents and Young Adults with Youth-Onset Type 1 or Type 2 Diabetes: A Proof-of-Concept Study
- Rotenone Induces a Neuropathological Phenotype in Cholinergic-like Neurons Resembling Parkinson's Disease Dementia (PDD)
- Bacteroidota inhibit microglia clearance of amyloid-beta and promote plaque deposition in Alzheimer's disease mouse models
- Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) After Infection During Pregnancy
- Cannabidiol and Neurodegeneration: From Molecular Mechanisms to Clinical Benefits
- Cannabidiol and Neurodegeneration: From Molecular Mechanisms to Clinical Benefits
- SARS-CoV-2 infects neurons, astrocytes, choroid plexus epithelial cells and pericytes of the human central nervous system in vitro
- Exploration of mitochondrial autophagy related genes in the diagnosis model construction and molecular marker mining of Alzheimer's disease based on multi-omics integration
- Divergent Associations of Slow-Wave Sleep versus Rapid Eye Movement Sleep with Plasma Amyloid-Beta
- SIK1 Downregulates Synaptic AMPA Receptors and Contributes to Cognitive Defects in Alzheimer's Disease
- Post-COVID-19 Suicide Note: A Case Report of Late Onset Catatonia
- Stem Cell Interventions in the Treatment of Alzheimer's Disease
- Psychomotor symptoms, cognitive impairments and suicidal thoughts after COVID-19 infection: a case report and the possible allostatic mechanism
- Short- and long-term neuropsychiatric outcomes in long COVID in South Korea and Japan
- G272V and P301L mutations induce isoform specific tau mislocalization to dendritic spines and synaptic dysfunctions in cellular models of 3R and 4R tau frontotemporal dementia
- Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
- Role of PIM Kinase Inhibitor in the Treatment of Alzheimer's Disease
- Sex-specific biphasic alpha-synuclein response and alterations of interneurons in a COVID-19 hamster model
- Evidence for a novel neuronal mechanism driving Alzheimer's disease, upstream of amyloid
- Norepinephrine Drives Sleep Fragmentation Activation of Asparagine Endopeptidase, Locus Coeruleus Degeneration and Hippocampal Amyloid-β42 Accumulation
- Assessing amyloid PET positivity and cognitive function in Down syndrome to guide clinical trials targeting amyloid
- Associations of hospital-treated infections with subsequent dementia: nationwide 30-year analysis
- BACE1 Inhibitors for Alzheimer's Disease: Current Challenges and Future Perspectives
- Generating PET scan patterns in Alzheimer's by a mathematical model
- Disease-Modifying Treatments and Their Future in Alzheimer's Disease Management
- Mitochondrial alterations in fibroblasts from sporadic Alzheimer's disease (AD) patients correlate with AD-related clinical hallmarks
- Alterations of human CSF and serum-based mitophagy biomarkers in the continuum of Alzheimer disease
- A clathrin mediated endocytosis scaffolding protein, Intersectin 1, changes in an isoform, brain region, and sex specific manner in Alzheimer's disease
- Abnormal EEG microstates in Alzheimer's disease: predictors of b-amyloid deposition degree and disease classification
- Specific Association of Worry With Amyloid-β But Not Tau in Cognitively Unimpaired Older Adults
- Neutral or detrimental effects of TREM2 agonist antibodies in preclinical models of Alzheimer's Disease and Multiple Sclerosis
- Cerebrospinal fluid biomarkers and cognitive trajectories in patients with Alzheimer's disease and a history of traumatic brain injury
- Tau follows principal axes of functional and structural brain organization in Alzheimer's disease
Evidence Blueprint
Molecular cross-talk between long COVID-19 and Alzheimer’s disease
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Molecular cross-talk between long COVID-19 and Alzheimer’s disease
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-β-associated pathology in APP/PS1 mouse model of Alzheimer's disease
- COVID-19 and Alzheimer's disease: Impact of lockdown and other restrictive measures during the COVID-19 pandemic
- Liver as a new target organ in Alzheimer's disease: insight from cholesterol metabolism and its role in amyloid-beta clearance
- COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future
- Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer's Disease
- Impact of apolipoprotein E isoforms on sporadic Alzheimer's disease: beyond the role of amyloid beta
- Alzheimer-Type Cerebral Amyloidosis in the Context of HIV Infection: Implications for a Proposed New Treatment Approach
- Microbial infection promotes amyloid pathology in a mouse model of Alzheimer's disease via modulating γ-secretase
- P2Y1 receptor in Alzheimer's disease
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- Neuropsychiatric symptoms associated with the COVID-19 and its potential nervous system infection mechanism: the role of imaging in the study
- Targeted examination of amyloid beta and tau protein accumulation via positron emission tomography for the differential diagnosis of Alzheimer's disease based on the A/T(N) research framework
- Prevalence, pathogenesis and spectrum of neurological symptoms in COVID-19 and post-COVID-19 syndrome: a narrative review
- Is Alzheimer disease a disease?
- Role of Oxidative Stress, Methionine Oxidation and Methionine Sulfoxide Reductases (MSR) in Alzheimer's Disease
- Hypoglycemia and Alzheimer Disease Risk: The Possible Role of Dasiglucagon
- Mistranslation-associated perturbations of proteostasis do not promote accumulation of amyloid beta and plaque deposition in aged mouse brain
- 9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models
- 9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models
- Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer's disease
- CSF 14-3-3β is associated with progressive cognitive decline in Alzheimer's disease
- Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study
- A case of late-onset organizing pneumonia following COVID-19 infection in a post-kidney transplant patient
- VEEV TC-83 Triggers Dysregulation of the Tryptophan-Kynurenine Pathway in the Central Nervous System That Correlates with Cognitive Impairment in Tg2576 Mice
- Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury
- Extracellular vesicle proteome unveils cathepsin B connection to Alzheimer's disease pathogenesis
- Traumatic Brain Injury in Mice Generates Early-Stage Alzheimer's Disease Related Protein Pathology that Correlates with Neurobehavioral Deficits
- Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early- and late-phase COVID-19
- Amyloid Targeting Red Emitting AIE Dots for Diagnostic and Therapeutic Application against Alzheimer's Disease
- Investigating the Potential Shared Molecular Mechanisms between COVID-19 and Alzheimer's Disease via Transcriptomic Analysis
- Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease
- Multiple system atrophy with amyloid-b-predominant Alzheimer's disease neuropathologic change
- Compounding for the Treatment of COVID-19 and Long COVID, Part 4: The Legacy of Chronic COVID
- Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
- Alzheimer's Type Neuropathological Changes in a Patient with Depression and Anxiety: A Case Report and Literature Review of Neuropathological Correlates of Neuropsychiatric Symptoms in Alzheimer's Disease
- Primary Hypothyroidism and Alzheimer's Disease: A Tale of Two
- Interactions between vascular burden and amyloid-β pathology on trajectories of tau accumulation
- Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis Patients
- Memantine versus Ginkgo biloba Extract: A Comparative Study on Cognitive Dysfunction Treatment in a Novel Rat Model
- Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer's disease
- Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer's disease
- Treatment of the CRND8 mouse model for cerebral amyloid angiopathy, exhibited increased levels of neuron specific enolase in brain tissue following long-term treatment with a modified C5a receptor agonist, accompanied by improved cognitive function
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Human iPSC-derived retinal organoids develop robust Alzheimer's disease neuropathology
- Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease
- Understanding the neurological implications of acute and long COVID using brain organoids
- Whole genome-wide sequence analysis of long-lived families (Long-Life Family Study) identifies MTUS2 gene associated with late-onset Alzheimer's disease
- Gypenoside IX restores Akt/GSK-3β pathway and alleviates Alzheimer's disease-like neuropathology and cognitive deficits
- CSF protein ratios with enhanced potential to reflect Alzheimer's disease pathology and neurodegeneration
- Towards cascading genetic risk in Alzheimer's disease
- Transcending the amyloid-beta dominance paradigm in Alzheimer's disease: An exploration of behavioural, metabolic, and gut microbiota phenotypes in 5xFAD mice
- Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update
- Neuropsychiatric outcomes and sleep dysfunction in COVID-19 patients: risk factors and mechanisms
- SARS-CoV-2-associated T-cell infiltration in the central nervous system
- Subsequent correlated changes in complement component 3 and amyloid beta oligomers in the blood of patients with Alzheimer's disease
- Phytoactive drugs used in the treatment of Alzheimer's disease and dementia
- Anti-amyloid antibody treatments for Alzheimer's disease
- p-tau Ser356 is associated with Alzheimer's disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003
- The Multisystem effects of Long COVID Syndrome and Potential Benefits of Massage Therapy in Long COVID Care
- The Gut Microbiota-Brain Axis: A New Frontier in Alzheimer's Disease Pathology
- Neuropathological and sociodemographic factors associated with the cortical amyloid load in aging and Alzheimer's disease
- Co-registration of MALDI-MSI and histology demonstrates gangliosides co-localize with amyloid beta plaques in Alzheimer's disease
- Co-registration of MALDI-MSI and histology demonstrates gangliosides co-localize with amyloid beta plaques in Alzheimer's disease
- The Role of RIN3 Gene in Alzheimer's Disease Pathogenesis: a Comprehensive Review